Literature DB >> 9227697

Multiple-dose mannitol reduces brain water content in a rat model of cortical infarction.

R P Paczynski1, Y Y He, M N Diringer, C Y Hsu.   

Abstract

BACKGROUND AND
PURPOSE: Repeated use of mannitol in the setting of ischemic infarction is a controversial and poorly defined therapeutic intervention. The purpose of this study was to examine the effects of repeated mannitol infusions on brain water content and tissue pressure in a well-defined rat model of focal ischemic stroke.
METHODS: Mannitol infusions (0.5, 1.5, or 2.5 g/kg) were given by intravenous bolus 4 or 24 hours after 90-minute transient cortical ischemia in the territory of the right middle cerebral artery in rats and every 4 hours thereafter for a total of 24 hours. Fluid replacement was limited to 0.5 mL i.v. isotonic saline administered immediately after each mannitol dose. Control rats received 0.5 mL i.v. saline at the same intervals and were otherwise under ad libitum conditions. Water contents (percent H2O) of whole hemispheres and of cortical biopsies were measured with the wet-dry method, and blood samples were analyzed for plasma osmolality and chemistries. In a subgroup of rats, tissue pressure was also measured within the hemisphere ipsilateral to the infarct.
RESULTS: Repeated mannitol infusions resulted in a dose-dependent increase in plasma osmolality and a dose-dependent decrease in the percent H2O of the ischemic middle cerebral artery cortex and ipsilateral hemisphere. In contrast, percent H2O of the contralateral cortex and hemisphere was significantly decreased only in the groups given the highest dose of mannitol (2.5 g/kg). Mannitol infusions at a dose of 1.5 g/kg begun 24 hours after reperfusion were also associated with a significant reduction of tissue pressure.
CONCLUSIONS: In a rat model of ischemic cortical infarction, repeated mannitol infusions resulted primarily in a decrease in the percent H2O of the infarct and ipsilateral hemisphere, as well as decreased tissue pressure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9227697     DOI: 10.1161/01.str.28.7.1437

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  17 in total

1.  Mass Effect with Cerebral Infarction.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-07       Impact factor: 3.598

Review 2.  Osmotic therapy: fact and fiction.

Authors:  Michael N Diringer; Allyson R Zazulia
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

3.  Cerebral hemodynamic and metabolic effects of equi-osmolar doses mannitol and 23.4% saline in patients with edema following large ischemic stroke.

Authors:  Michael N Diringer; Michael T Scalfani; Allyson R Zazulia; Tom O Videen; Raj Dhar
Journal:  Neurocrit Care       Date:  2011-02       Impact factor: 3.210

4.  Variation in osmotic response to sustained mannitol administration.

Authors:  Salah G Keyrouz; Rajat Dhar; Michael N Diringer
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

5.  A bolus of conivaptan lowers intracranial pressure in a patient with hyponatremia after traumatic brain injury.

Authors:  Rajat Dhar; Theresa Murphy-Human
Journal:  Neurocrit Care       Date:  2011-02       Impact factor: 3.210

Review 6.  Osmotherapy for elevated intracranial pressure: a critical reappraisal.

Authors:  R Nau
Journal:  Clin Pharmacokinet       Date:  2000-01       Impact factor: 6.447

7.  Cortical spreading depression activates and upregulates MMP-9.

Authors:  Yasemin Gursoy-Ozdemir; Jianhua Qiu; Norihiro Matsuoka; Hayrunnisa Bolay; Daniela Bermpohl; Hongwei Jin; Xiaoying Wang; Gary A Rosenberg; Eng H Lo; Michael A Moskowitz
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

8.  Accumulated mannitol and aggravated cerebral edema in a rat model of middle cerebral artery infarction.

Authors:  Jaeman Cho; Yeon-Hee Kim; Hyung Soo Han; Jaechan Park
Journal:  J Korean Neurosurg Soc       Date:  2007-10-20

9.  Outcome Differences between Intra-Arterial Iso- and Low-Osmolality Iodinated Radiographic Contrast Media in the Interventional Management of Stroke III Trial.

Authors:  T A Tomsick; L D Foster; D S Liebeskind; M D Hill; J Carrozella; M Goyal; R von Kummer; A M Demchuk; I Dzialowski; V Puetz; T Jovin; H Morales; Y Y Palesch; J Broderick; P Khatri; S D Yeatts
Journal:  AJNR Am J Neuroradiol       Date:  2015-07-30       Impact factor: 3.825

10.  Mannitol enhances delivery of marrow stromal cells to the brain after experimental intracerebral hemorrhage.

Authors:  Donald M Seyfried; Yuxia Han; Dongmei Yang; Jennifer Ding; Smita Savant-Bhonsale; Mohammad S Shukairy; Michael Chopp
Journal:  Brain Res       Date:  2008-06-10       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.